These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7740998)

  • 1. Animal models of hepatic encephalopathy and hyperammonemia.
    Mullen KD; Birgisson S; Gacad RC; Conjeevaram H
    Adv Exp Med Biol; 1994; 368():1-10. PubMed ID: 7740998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
    Conjeevaram HS; Nagle A; Katz A; Kaminsky-Russ K; McCullough AJ; Mullen KD
    Hepatology; 1994 May; 19(5):1245-50. PubMed ID: 8175148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the metabolic disturbances caused by end-to-side and side-to-side portacaval shunts.
    Hawkins PA; DeJoseph MR; Viña JR; Hawkins RA
    J Appl Physiol (1985); 1996 Mar; 80(3):885-91. PubMed ID: 8964752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of lactitol (NS-4) on the increase in blood and brain ammonia concentration and on coma in newly developed rat models of hepatic coma].
    Watanabe M; Ozaki T; Hirata Y; Yoshikuni Y; Kimura K
    Nihon Yakurigaku Zasshi; 1995 Feb; 105(2):97-109. PubMed ID: 7737597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portacaval anastomosis-induced hyperammonemia does not lead to oxidative stress.
    Yang X; Bosoi CR; Jiang W; Tremblay M; Rose CF
    Metab Brain Dis; 2010 Mar; 25(1):11-5. PubMed ID: 20195725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic ATP content and hyperammonemia induced by CCl4 in rats.
    Yamamoto HA; Sugihara N
    Toxicology; 1988 Sep; 51(1):111-7. PubMed ID: 3413798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploratory investigation on nitro- and phospho-proteome cerebellum changes in hyperammonemia and hepatic encephalopathy rat models.
    Brunelli L; Campagna R; Airoldi L; Cauli O; Llansola M; Boix J; Felipo V; Pastorelli R
    Metab Brain Dis; 2012 Mar; 27(1):37-49. PubMed ID: 22083566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models in the study of episodic hepatic encephalopathy in cirrhosis.
    Jover R; Madaria E; Felipo V; Rodrigo R; Candela A; Compañ A
    Metab Brain Dis; 2005 Dec; 20(4):399-408. PubMed ID: 16382350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arginase and experimental hyperammoniemia. II. Action of arginase on experimental portacaval encephalopathy in the dog].
    AIMARD G; MAILLET P; VILLAROS J; DUFFRENE D
    Presse Med (1893); 1962 May; 70():1204-6. PubMed ID: 13859792
    [No Abstract]   [Full Text] [Related]  

  • 10. Precipitation of overt encephalopathy in the portacaval shunted rat: towards the development of an adequate model of chronic portal systemic encephalopathy.
    Mullen KD; Roessle M; Jones DB; Grun M; Jones EA
    Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):293-8. PubMed ID: 9096433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood ammonia levels and hepatic encephalopathy induced by CCl4 in rats.
    Yamamoto H; Sugihara N
    Toxicol Appl Pharmacol; 1987 Dec; 91(3):461-8. PubMed ID: 2962338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.
    Vogels BA; Maas MA; Daalhuisen J; Quack G; Chamuleau RA
    Hepatology; 1997 Apr; 25(4):820-7. PubMed ID: 9096582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-dependent reduction of spontaneous motor activity and growth in rats subjected to portacaval shunt.
    Conjeevaram HS; Mullen KD; May EJ; McCullough AJ
    Hepatology; 1994 Feb; 19(2):381-8. PubMed ID: 8294095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems with animal models of chronic liver disease: suggestions for improvement in standardization.
    Mullen KD; McCullough AJ
    Hepatology; 1989 Mar; 9(3):500-3. PubMed ID: 2921000
    [No Abstract]   [Full Text] [Related]  

  • 15. A surgical model of fulminant hepatic failure in the rabbit: different effects of end-to-side versus small-diameter side-to-side portacaval shunt.
    Fick TE; Schalm SW; de Vlieger M
    Eur Surg Res; 1987; 19(5):276-82. PubMed ID: 3653155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and electroencephalographic studies of beagles with an Eck's fistula: suitability as a model of hepatic encephalopathy.
    Watanabe M; Ozaki T; Mushiroi T; Ukai Y; Ueda F; Kimura K; Katoh M; Matsumoto A; Kotani E; Itoh S; Yamaguchi K; Kyuki K
    Pharmacol Biochem Behav; 1997; 57(1-2):367-75. PubMed ID: 9164596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portacaval shunting causes differential mitochondrial superoxide production in brain regions.
    Kosenko EA; Tikhonova LA; Alilova GA; Montoliu C; Barreto GE; Aliev G; Kaminsky YG
    Free Radic Biol Med; 2017 Dec; 113():109-118. PubMed ID: 28964916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin brain circuits with a focus on hepatic encephalopathy.
    Lozeva-Thomas V
    Metab Brain Dis; 2004 Dec; 19(3-4):413-20. PubMed ID: 15554431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inhibition of brain protein synthesis after portacaval shunting. A possible pathogenic mechanism in chronic hepatic encephalopathy in the rat.
    Wasterlain CG; Lockwood AH; Conn M
    Neurology; 1978 Mar; 28(3):233-8. PubMed ID: 564477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.
    Hadjihambi A; De Chiara F; Hosford PS; Habtetion A; Karagiannis A; Davies N; Gourine AV; Jalan R
    Hepatology; 2017 Apr; 65(4):1306-1318. PubMed ID: 28066916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.